ReviewTherapeutic innovation & regulatory science2024

Advanced Regenerative Medicines for Rare Diseases: A Review of Industry Sponsors Investment Motivations.

Ubaka Ogbogu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.